You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Adverse Drug Reactions Advisory Committee (ADRAC)
The Adverse Drug Reactions Advisory Committee (ADRAC) was a subcommittee of the Australian Drug Evaluation Committee (ADEC) and was formed in 1970 to advise the TGA on the safety of medicines. It was composed of independent medical experts who have expertise in areas of importance to the evaluation of medicine safety.
In 2010, ADRAC was replaced by the Advisory Committee on the Safety of Medicines (ACSOM).